ProfileGDS5822 / ILMN_2800051
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 78% 79% 81% 81% 80% 78% 85% 81% 79% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1110.678
GSM1276600PDAC Late Ablation Control 2135.579
GSM1276601PDAC Late Ablation Control 3226.481
GSM1276602PDAC Late Ablation 1149.481
GSM1276603PDAC Late Ablation 2157.980
GSM1276604PDAC Late Ablation 3130.178
GSM1303940PDAC Late Ablation_anti-CTLA4 1232.785
GSM1303941PDAC Late Ablation_anti-CTLA4 2208.981
GSM1303942PDAC Late Ablation_anti-CTLA4 3162.179